NO142624C - Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater - Google Patents
Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivaterInfo
- Publication number
- NO142624C NO142624C NO791507A NO791507A NO142624C NO 142624 C NO142624 C NO 142624C NO 791507 A NO791507 A NO 791507A NO 791507 A NO791507 A NO 791507A NO 142624 C NO142624 C NO 142624C
- Authority
- NO
- Norway
- Prior art keywords
- aminoamphetamine
- intermediates
- derivatives
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7312001A SE382047B (sv) | 1973-09-04 | 1973-09-04 | Forfarande for framstellning av 4-aminoamfetaminderivat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO791507L NO791507L (no) | 1975-03-05 |
| NO142624B NO142624B (no) | 1980-06-09 |
| NO142624C true NO142624C (no) | 1980-09-17 |
Family
ID=20318423
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743177A NO139408C (no) | 1973-09-04 | 1974-09-04 | Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt |
| NO791507A NO142624C (no) | 1973-09-04 | 1979-05-04 | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743177A NO139408C (no) | 1973-09-04 | 1974-09-04 | Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3996381A (no) |
| JP (1) | JPS5835177B2 (no) |
| AT (1) | AT336566B (no) |
| BE (1) | BE819515A (no) |
| CA (1) | CA1051436A (no) |
| CH (2) | CH603547A5 (no) |
| DE (1) | DE2440734C2 (no) |
| DK (1) | DK139716B (no) |
| FI (1) | FI62281C (no) |
| FR (1) | FR2242079B1 (no) |
| GB (1) | GB1461667A (no) |
| HK (1) | HK75778A (no) |
| IE (1) | IE40514B1 (no) |
| LU (1) | LU70852A1 (no) |
| NL (1) | NL7411753A (no) |
| NO (2) | NO139408C (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
| US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
| WO2002039998A2 (en) * | 2000-11-01 | 2002-05-23 | Sention, Inc. | Methods and compositions for regulating memory consolidation |
| US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
| US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
| US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3117160A (en) * | 1961-07-27 | 1964-01-07 | Pfizer & Co C | Aralkylamines |
| US3496195A (en) * | 1966-05-11 | 1970-02-17 | Chinoin Gyogyszer Es Vegyeszet | D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts |
-
1974
- 1974-08-14 US US05/497,295 patent/US3996381A/en not_active Expired - Lifetime
- 1974-08-24 DE DE2440734A patent/DE2440734C2/de not_active Expired
- 1974-08-30 AT AT702574A patent/AT336566B/de not_active IP Right Cessation
- 1974-09-03 IE IE1824/74A patent/IE40514B1/xx unknown
- 1974-09-03 CA CA208,356A patent/CA1051436A/en not_active Expired
- 1974-09-03 CH CH1173577A patent/CH603547A5/xx not_active IP Right Cessation
- 1974-09-03 JP JP49100618A patent/JPS5835177B2/ja not_active Expired
- 1974-09-03 GB GB3849974A patent/GB1461667A/en not_active Expired
- 1974-09-03 CH CH1195874A patent/CH599106A5/xx not_active IP Right Cessation
- 1974-09-03 FI FI2576/74A patent/FI62281C/fi active
- 1974-09-03 DK DK464774AA patent/DK139716B/da not_active IP Right Cessation
- 1974-09-03 FR FR7429970A patent/FR2242079B1/fr not_active Expired
- 1974-09-04 BE BE148180A patent/BE819515A/xx not_active IP Right Cessation
- 1974-09-04 LU LU70852A patent/LU70852A1/xx unknown
- 1974-09-04 NL NL7411753A patent/NL7411753A/xx not_active Application Discontinuation
- 1974-09-04 NO NO743177A patent/NO139408C/no unknown
-
1978
- 1978-12-28 HK HK757/78A patent/HK75778A/xx unknown
-
1979
- 1979-05-04 NO NO791507A patent/NO142624C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO139408B (no) | 1978-11-27 |
| JPS5050329A (no) | 1975-05-06 |
| IE40514B1 (en) | 1979-06-20 |
| GB1461667A (en) | 1977-01-19 |
| FI62281C (fi) | 1982-12-10 |
| CA1051436A (en) | 1979-03-27 |
| LU70852A1 (no) | 1975-06-11 |
| JPS5835177B2 (ja) | 1983-08-01 |
| FR2242079A1 (no) | 1975-03-28 |
| ATA702574A (de) | 1976-09-15 |
| FR2242079B1 (no) | 1978-07-21 |
| FI257674A (no) | 1975-03-05 |
| AT336566B (de) | 1977-05-10 |
| DK139716C (no) | 1979-09-17 |
| DK139716B (da) | 1979-04-02 |
| IE40514L (en) | 1975-03-04 |
| NL7411753A (nl) | 1975-03-06 |
| NO142624B (no) | 1980-06-09 |
| NO791507L (no) | 1975-03-05 |
| CH603547A5 (no) | 1978-08-31 |
| DE2440734A1 (de) | 1975-03-13 |
| US3996381A (en) | 1976-12-07 |
| DK464774A (no) | 1975-05-05 |
| NO139408C (no) | 1979-03-07 |
| HK75778A (en) | 1979-01-05 |
| NO743177L (no) | 1975-04-01 |
| AU7283374A (en) | 1976-03-04 |
| FI62281B (fi) | 1982-08-31 |
| CH599106A5 (no) | 1978-05-12 |
| DE2440734C2 (de) | 1985-01-24 |
| BE819515A (fr) | 1975-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR201880A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol | |
| NO143747C (no) | Carboxyalkylestere av n-fosfonmethylglycin for anvendelse som herbicide midler | |
| MX152550A (es) | Procedimiento para la preparacion de derivados de fenilnonatetraenos substituidos | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| SE7908625L (sv) | Acetylglykosylmykofenolsyraforeningar for framstellning av glykosylmykofenolsyraforeningar | |
| NO148377C (no) | 3-klor-7-alfa-amino-acylcefalosporinforbindelser for anvendelse som mellomprodukter ved fremstilling av terapeutisk virksomme cefalosporinderivater | |
| SE420604B (sv) | Forfarande for framstellning av oxazolderivat | |
| SE7712151L (sv) | Forfarande for framstellning av linkomycinderivat | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| SE417958B (sv) | Azetidinderivat for anvendning som mellanprodukt for framstellning av delta?723-desacetoxicefalosporansyraderivat och framstellning av azetidinderivat | |
| NO843825L (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin | |
| NO142624C (no) | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater | |
| SE7608956L (sv) | Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler | |
| AR207445A1 (es) | Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas | |
| SE7613500L (sv) | Forfarande for framstellning av cefemderivat | |
| NO148376C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO139125C (no) | Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater | |
| NO144018C (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser | |
| AR209281A1 (es) | Procedimiento de preparacion de derivados de ciclopropilfenilpirrolidina | |
| IT1021948B (it) | Procedimento per la preparazione di antrachinoni i sostituiti | |
| SE409325B (sv) | Forfarande for framstellning av kinazolinonderivat | |
| SE406086B (sv) | Forfarande for framstellning av cyklisk-dikarboximido-substituerade fosfonotioater | |
| NO141895C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nitroimidazolderivater |